Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital

• Conditions: Hemorrhage; Shock

• Registration Number: NCT00192933
• Lead Sponsor: Rigshospitalet, Denmark

Brief Summary

The purpose is to evaluate and improve NovoSeven treatment practice done according to our guidelines

Detailed Description

Not available

Study Timeline

• Study Start: 2000-01
• Status Verified: 2005-09
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-19
• Last Update Submitted: 2006-10-18
• Last Update Posted: 2006-10-19
• Study Completion: 2010-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Indication for NovoSeven treatment according to our guideline

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Rigshospitalet, Copenhagen University Hospital; 🇩🇰 Copenhagen, Denmark